Related Experiment Video
Updated: Jan 27, 2026

Author Spotlight: Unveiling Plankton Response to Climate Change Through Time-Series Data and Artistic Expression
Published on: July 28, 2023
Biodiversity Drives Micropollutant Biotransformation in Freshwater Phytoplankton Assemblages
Michael A Stravs1,2, Francesco Pomati1,3, Juliane Hollender1,2
1Swiss Federal Institute of Aquatic Science and Technology , Eawag , Überlandstrasse 133 , 8600 Dübendorf , Switzerland.
Abstract:
Biotransformation of chemical pollutants is an ecological process requiring multifunctionality (multiple metabolic pathways) and, potentially, high biodiversity. Phytoplankton communities are highly diverse functionally and taxonomically and co-occur with complex mixtures of organic pollutants in aquatic environments. Here, we investigated how phytoplankton species richness (SR) and class richness (CR) determine the biotransformation of a mixture of 37 structurally diverse pollutants using laboratory experiments and analysis of high-resolution mass spectrometry data. Laboratory phytoplankton communities were assembled from pure cultures by creating a gradient from one to five taxonomic groups, and 5 to 11 total species, in defined medium. The biotransformation of pollutants over 6 days and the total number of transformed chemicals increased with CR for 13 considerably transformed compounds. The total number of transformation products (TPs, up to 42) was positively affected by both CR and SR: CR had a positive effect on stable TPs found, and SR led to more transient TPs. Our data indicate that both taxonomic and functional diversity are important for biotransformation of anthropogenic chemicals in phytoplankton and suggest that plankton biodiversity could play a role in the remediation of pollutant loads in aquatic ecosystems.
Related Concept Videos
What is Biodiversity?
Threats to Biodiversity
Biodiversity and Human Values
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

